These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15853666)

  • 1. New methodologies for ligand-based virtual screening.
    Stahura FL; Bajorath J
    Curr Pharm Des; 2005; 11(9):1189-202. PubMed ID: 15853666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening in drug discovery -- a computational perspective.
    Reddy AS; Pati SP; Kumar PP; Pradeep HN; Sastry GN
    Curr Protein Pept Sci; 2007 Aug; 8(4):329-51. PubMed ID: 17696867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of machine learning methods for ligand-based virtual screening.
    Plewczynski D; Spieser SA; Koch U
    Comb Chem High Throughput Screen; 2009 May; 12(4):358-68. PubMed ID: 19442065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual high-throughput screening of molecular databases.
    Seifert MH; Kraus J; Kramer B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent development and application of virtual screening in drug discovery: an overview.
    Hou T; Xu X
    Curr Pharm Des; 2004; 10(9):1011-33. PubMed ID: 15078130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking: successes and challenges.
    Mohan V; Gibbs AC; Cummings MD; Jaeger EP; DesJarlais RL
    Curr Pharm Des; 2005; 11(3):323-33. PubMed ID: 15723628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of virtual screening as analysed by target class.
    Stoermer MJ
    Med Chem; 2006 Jan; 2(1):89-112. PubMed ID: 16787359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition.
    Wei NN; Hamza A
    J Chem Inf Model; 2014 Jan; 54(1):338-46. PubMed ID: 24328054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of virtual compound screening.
    Heikamp K; Bajorath J
    Chem Biol Drug Des; 2013 Jan; 81(1):33-40. PubMed ID: 23253129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
    Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
    J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational methodologies for compound database searching that utilize experimental protein-ligand interaction information.
    Tan L; Batista J; Bajorath J
    Chem Biol Drug Des; 2010 Sep; 76(3):191-200. PubMed ID: 20636330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of structure based virtual screening in the early phase of drug discovery].
    Polgár T
    Acta Pharm Hung; 2007; 77(4):223-34. PubMed ID: 18290542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boosting virtual screening enrichments with data fusion: coalescing hits from two-dimensional fingerprints, shape, and docking.
    Sastry GM; Inakollu VS; Sherman W
    J Chem Inf Model; 2013 Jul; 53(7):1531-42. PubMed ID: 23782297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational protein-ligand docking and virtual drug screening with the AutoDock suite.
    Forli S; Huey R; Pique ME; Sanner MF; Goodsell DS; Olson AJ
    Nat Protoc; 2016 May; 11(5):905-19. PubMed ID: 27077332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to benchmark methods for structure-based virtual screening of large compound libraries.
    Christofferson AJ; Huang N
    Methods Mol Biol; 2012; 819():187-95. PubMed ID: 22183538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
    Rester U
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screening in drug design.
    Lill M
    Methods Mol Biol; 2013; 993():1-12. PubMed ID: 23568460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace.
    Singh N; Chaput L; Villoutreix BO
    Brief Bioinform; 2021 Mar; 22(2):1790-1818. PubMed ID: 32187356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.